523 related articles for article (PubMed ID: 12849400)
1. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?
Ikonomidou C; Turski L
Lancet Neurol; 2002 Oct; 1(6):383-6. PubMed ID: 12849400
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience with excitatory amino acid antagonist drugs.
Muir KW; Lees KR
Stroke; 1995 Mar; 26(3):503-13. PubMed ID: 7886734
[TBL] [Abstract][Full Text] [Related]
3. Cerestat and other NMDA antagonists in ischemic stroke.
Lees KR
Neurology; 1997 Nov; 49(5 Suppl 4):S66-9. PubMed ID: 9371155
[TBL] [Abstract][Full Text] [Related]
4. The rise and fall of NMDA antagonists for ischemic stroke.
Hoyte L; Barber PA; Buchan AM; Hill MD
Curr Mol Med; 2004 Mar; 4(2):131-6. PubMed ID: 15032709
[TBL] [Abstract][Full Text] [Related]
5. Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists.
Muir KW
Curr Opin Pharmacol; 2006 Feb; 6(1):53-60. PubMed ID: 16359918
[TBL] [Abstract][Full Text] [Related]
6. Glutamate AMPA receptor antagonist treatment for ischaemic stroke.
Akins PT; Atkinson RP
Curr Med Res Opin; 2002; 18 Suppl 2():s9-13. PubMed ID: 12365832
[TBL] [Abstract][Full Text] [Related]
7. Excitatory amino acid antagonists for acute stroke.
Muir KW; Lees KR
Cochrane Database Syst Rev; 2003; 2003(3):CD001244. PubMed ID: 12917902
[TBL] [Abstract][Full Text] [Related]
8. NMDA receptor antagonists and glycine site NMDA antagonists.
Madden K
Curr Med Res Opin; 2002; 18 Suppl 2():s27-31. PubMed ID: 12365826
[TBL] [Abstract][Full Text] [Related]
9. Is it time to conclude that NMDA antagonists have failed?
Roesler R; Quevedo J; Schröder N
Lancet Neurol; 2003 Jan; 2(1):13; discussion 13. PubMed ID: 12849294
[No Abstract] [Full Text] [Related]
10. N-methyl-D-aspartate antagonists for stroke and head trauma.
Wood PL; Hawkinson JE
Expert Opin Investig Drugs; 1997 Apr; 6(4):389-97. PubMed ID: 15989606
[TBL] [Abstract][Full Text] [Related]
11. Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults.
Lipton SA
NeuroRx; 2004 Jan; 1(1):101-10. PubMed ID: 15717010
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methylguanidines as N-methyl-D-aspartate receptor ion-channel blockers.
Hu LY; Guo J; Magar SS; Fischer JB; Burke-Howie KJ; Durant GJ
J Med Chem; 1997 Dec; 40(26):4281-9. PubMed ID: 9435897
[TBL] [Abstract][Full Text] [Related]
13. Why do many NMDA antagonists fail, while others are safe and effective at blocking excitotoxicity associated with dementia and acute injury?
Albensi BC; Igoechi C; Janigro D; Ilkanich E
Am J Alzheimers Dis Other Demen; 2004; 19(5):269-74. PubMed ID: 15553982
[TBL] [Abstract][Full Text] [Related]
14. The chemical biology of clinically tolerated NMDA receptor antagonists.
Chen HS; Lipton SA
J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
[TBL] [Abstract][Full Text] [Related]
15. Is high extracellular glutamate the key to excitotoxicity in traumatic brain injury?
Obrenovitch TP; Urenjak J
J Neurotrauma; 1997 Oct; 14(10):677-98. PubMed ID: 9383088
[TBL] [Abstract][Full Text] [Related]
16. Competitive Gly/NMDA receptor antagonists.
Catarzi D; Colotta V; Varano F
Curr Top Med Chem; 2006; 6(8):809-21. PubMed ID: 16719819
[TBL] [Abstract][Full Text] [Related]
17. The NMDA receptor complex: a long and winding road to therapeutics.
Wood PL
IDrugs; 2005 Mar; 8(3):229-35. PubMed ID: 15772895
[TBL] [Abstract][Full Text] [Related]
18. NMDA/NR2B selective antagonists in the treatment of ischemic brain injury.
Wang CX; Shuaib A
Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):143-51. PubMed ID: 15857299
[TBL] [Abstract][Full Text] [Related]
19. mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors.
Movsesyan VA; O'Leary DM; Fan L; Bao W; Mullins PG; Knoblach SM; Faden AI
J Pharmacol Exp Ther; 2001 Jan; 296(1):41-7. PubMed ID: 11123360
[TBL] [Abstract][Full Text] [Related]
20. Selective blockade of the mGluR1 receptor reduces traumatic neuronal injury in vitro and improvesoOutcome after brain trauma.
Faden AI; O'Leary DM; Fan L; Bao W; Mullins PG; Movsesyan VA
Exp Neurol; 2001 Feb; 167(2):435-44. PubMed ID: 11161632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
